Arcturus Therapeutics Holdings Inc. (ARCT) Investor Relations Documents

Arcturus Therapeutics Holdings Inc. (ARCT) investor relations documents from the company's IR site: 2 presentations, 35 press releases; latest deck 2026-08-06. Read in-app with summaries. First-party data.

Corporate Deck August 2026: Arcturus Therapeutics is an mRNA medicine company developing LUNAR-delivered therapies, highlighted by positive interim Phase 2 mucus reduction data for ARCT-032.

Investor relations documents — source: company IR site
PublishedTypeDocument
2026-08-06PresentationCorporate Deck August 2026
2026-08-06Press releasePDF Version
2026-08-06Press releaseArcturus Therapeutics Announces Second Quarter 2026 Financial Results and Pipeline Progress
2026-07-28Press releasePDF Version
2026-07-28Press releaseArcturus Therapeutics to Report Second Quarter Financial Results and Provide Corporate Update on Aug 6, 2026
2026-07-20Press releasePDF Version
2026-07-20Press releaseArcturus Therapeutics to Present at the Canaccord Genuity 46th Annual Growth Conference
2026-07-02Press releasePDF Version
2026-07-02Press releaseArcturus Therapeutics Announces Strategic Collaboration with Thermo Fisher Scientific to Advance ARCT-032 for Cystic Fib
2026-05-26Press releasePDF Version
2026-05-26Press releaseArcturus Therapeutics to Present at 2026 Jefferies Global Healthcare Conference
2026-05-07Press releasePDF Version
2026-05-07Press releaseArcturus Therapeutics Announces First Quarter 2026 Financial Results and Pipeline Progress
2026-04-27Press releasePDF Version
2026-04-27Press releaseArcturus Therapeutics to Report First Quarter Financial Results and Provide Corporate Update on May 7, 2026
2026-03-05Press releasePDF Version
2026-03-05Press releaseArcturus Therapeutics to Attend Upcoming Investor Conference
2026-03-03Press releasePDF Version
2026-03-03Press releaseArcturus Therapeutics Announces Fourth Quarter and Fiscal Year 2025 Financial Results and Pipeline Progress
2026-02-17Press releasePDF Version
2026-02-17Press releaseArcturus Therapeutics to Report Fourth Quarter and Fiscal Year 2025 Financial Results and Provide Corporate Update on Ma
2026-01-12PresentationJanuary 2026- 44th Annual J.P. Morgan Healthcare Conference
2026-01-08Press releasePDF Version
2026-01-08Press releaseArcturus Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
DocumentArcturus Therapeutics Announces Third Quarter 2025 Financial Update and Pipeline Progress
DocumentArcturus Therapeutics Announces Second Quarter 2025 Financial Update and Pipeline Progress
DocumentArcturus Therapeutics Announces First Quarter 2025 Financial Update and Pipeline Progress
Press releaseArcturus Therapeutics Announces Fourth Quarter and Fiscal Year 2024 Financial Update and Pipeline Progress
2024-08-05Press releaseArcturus Therapeutics Announces Second Quarter 2024 Financial Update and Pipeline Progress
2024-05-08Press releaseArcturus Therapeutics Announces First Quarter 2024 Financial Update and Pipeline Progress
2024-03-07Press releaseArcturus Therapeutics Announces Fourth Quarter and Fiscal Year 2023 Financial Update and Pipeline Progress
2023-11-14Press releaseArcturus Therapeutics Announces Third Quarter 2023 Financial Update and Pipeline Progress
2023-08-07Press releaseArcturus Therapeutics Announces Second Quarter 2023 Financial Update and Pipeline Progress
2023-05-09Press releaseArcturus Therapeutics Announces First Quarter 2023 Financial Update and Pipeline Progress
2023-03-28Press releaseArcturus Therapeutics Announces Fourth Quarter 2022 Financial Update and Pipeline Progress
2022-11-09Press releaseArcturus Therapeutics Announces Third Quarter 2022 Financial Update and Pipeline Progress
2022-08-09Press releaseArcturus Therapeutics Announces Second Quarter 2022 Financial Update and Pipeline Progress
2022-05-09Press releaseArcturus Therapeutics Announces First Quarter 2022 Financial Update and Pipeline Progress
2022-02-28Press releaseArcturus Therapeutics Announces Fourth Quarter and Full Year 2021 Financial Update and Pipeline Progress
2021-11-08Press releaseArcturus Therapeutics Announces Third Quarter 2021 Financial Update and Pipeline Progress

ARCT overview · ARCT earnings · ARCT financials · ARCT KPIs · ARCT ownership · ARCT peers · ARCT filings

Documents published by the company on its investor-relations site; summaries are model-written. Not personalized investment advice.